PETS icon

PetMed Express

2.79 USD
-0.03
1.06%
At close Updated Sep 17, 3:59 PM EDT
1 day
-1.06%
5 days
2.57%
1 month
-8.52%
3 months
-20.06%
6 months
-30.25%
Year to date
-39.87%
1 year
-23.98%
5 years
-90.81%
10 years
-83.2%
 

About: PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.

Employees: 287

0
Funds holding %
of 7,463 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

104% more call options, than puts

Call options by funds: $821K | Put options by funds: $403K

2.3% less ownership

Funds ownership: 38.01% [Q1] → 35.71% (-2.3%) [Q2]

10% less funds holding

Funds holding: 71 [Q1] → 64 (-7) [Q2]

25% less capital invested

Capital invested by funds: $32.9M [Q1] → $24.6M (-$8.31M) [Q2]

50% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 14

67% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 30

Financial journalist opinion

Based on 3 articles about PETS published over the past 30 days

Neutral
GlobeNewsWire
8 days ago
PETMED INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating PetMed Express, Inc. on Behalf of PetMed Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partner  Brandon Walker  Encourages Investors Who Suffered Losses In PetMed (PETS) To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in PetMed and would like to discuss your legal rights, call Bragar Eagel & Squire partner  Brandon Walker or Marion Passmore directly at (212) 355-4648.
PETMED INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating PetMed Express, Inc. on Behalf of PetMed Stockholders and Encourages Investors to Contact the Firm
Neutral
GlobeNewsWire
28 days ago
PetMed Express, Inc. Investors: Company Investigated by the Portnoy Law Firm
Investors can contact the law firm at no cost to learn more about recovering their losses
PetMed Express, Inc. Investors: Company Investigated by the Portnoy Law Firm
Neutral
GlobeNewsWire
1 month ago
PetMeds Investor ALERT: Block & Leviton Investigating PetMed Express For Securities Fraud; Investors Should Contact the Firm To Potentially Recover Losses
Block & Leviton LLP is investigating PetMed Express (NASDAQ: PETS) for securities fraud. Investors who have lost money in PetMeds should contact the firm.
PetMeds Investor ALERT: Block & Leviton Investigating PetMed Express For Securities Fraud; Investors Should Contact the Firm To Potentially Recover Losses
Neutral
GlobeNewsWire
1 month ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS
NEW YORK, Aug. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of PetMed Express, Inc. (“PetMed” or the “Company”) (NASDAQ: PETS).  Such investors are advised to contact Danielle Peyton at  newaction@pomlaw.com  or 646-581-9980, ext. 7980.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS
Neutral
PRNewsWire
1 month ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS
NEW YORK , Aug. 16, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of PetMed Express, Inc. ("PetMed" or the "Company") (NASDAQ: PETS).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS
Neutral
GlobeNewsWire
1 month ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS
NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of PetMed Express, Inc. (“PetMed” or the “Company”) (NASDAQ: PETS). Such investors are advised to contact Danielle Peyton at  newaction@pomlaw.com  or 646-581-9980, ext. 7980.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS
Neutral
GlobeNewsWire
1 month ago
PetMed Express, Inc. Announces Management Changes
DELRAY BEACH, Fla., Aug. 12, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (the “Company”) dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today announced that its Chief Executive Officer, Sandra Campos, and Chief Financial Officer, Robyn D'Elia, have resigned from their positions and employment with the Company.
PetMed Express, Inc. Announces Management Changes
Neutral
PRNewsWire
1 month ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS
NEW YORK , Aug. 11, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of PetMed Express, Inc. ("PetMed" or the "Company") (NASDAQ: PETS).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS
Neutral
GlobeNewsWire
1 month ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS
NEW YORK, Aug. 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of PetMed Express, Inc. (“PetMed” or the “Company”) (NASDAQ: PETS).  Such investors are advised to contact Danielle Peyton at  newaction@pomlaw.com  or 646-581-9980, ext. 7980.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS
Neutral
PRNewsWire
1 month ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS
NEW YORK , Aug. 6, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of PetMed Express, Inc. ("PetMed" or the "Company") (NASDAQ: PETS).  Such investors are advised to contact Danielle Peyton at  newaction@pomlaw.com  or 646-581-9980, ext.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS
Charts implemented using Lightweight Charts™